• Clonidine Hydrochloride for Pain Relief During Eye Exams in Premature Infants with Retinopathy of Prematurity

    Recruiting

    3 1 1 1
    Investigated Drugs:
    Sweden

  • Study on the Safety and Effectiveness of Vibegron for Children Aged 2 to 17 with Neurogenic Bladder Overactivity Using Clean Intermittent Catheterization

    Recruiting

    4 1 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium Croatia Denmark Latvia Lithuania Norway +3

  • Study on Glofitamab, Venetoclax, and Zanubrutinib for Patients with Untreated or Relapsed High-Risk Mantle Cell Lymphoma

    Recruiting

    4 1 1 1
    Investigated Drugs:
    Belgium France

  • Study on Acalabrutinib for Adults with Chronic Lymphocytic Leukemia and Heart Issues

    Recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Czechia Italy Poland Spain

  • Study on the Safety and Effectiveness of Tregs and Rituximab for Children with Early Stage Type 1 Diabetes

    Recruiting

    2 1 1
    Investigated Drugs:
    Poland

  • Study on the Safety of EDV2209 for Patients with Brain Bleeding (Subarachnoid Hemorrhage)

    Recruiting

    2 1
    Investigated Diseases:
    Investigated Drugs:
    Denmark

  • Study on Botulinum Toxin for Patients with Degenerative Rotator Cuff Tendinopathy

    Recruiting

    2 1 1
    Investigated Diseases:
    Investigated Drugs:
    France

  • Study on the Effect of Norepinephrine Infusion for Managing Low Blood Pressure in Patients Undergoing Non-Cardiac Surgery

    Recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Poland

  • Study on Reducing Oral Side Effects of Talquetamab in Multiple Myeloma Patients Using Pregabalin, Dexamethasone, and Clonazepam

    Recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    The Netherlands Spain

  • Study on the Effectiveness of EHSG-KF Skin Graft for Patients with Deep Partial and Full-Thickness Burns

    Recruiting

    3 1 1
    Investigated Drugs:
    Belgium France Germany Italy The Netherlands Poland +2

powered by